drugset / Trial / NCT02475616
A Single Ascending Dose Study of PCO371 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a single-center, placebo-controlled, randomized, double-blind, dose-escalation study to evaluate safety, tolerability, and PK of a single oral (PO) administration of PCO371 in healthy adult males. Caucasian and Japanese subjects will be randomized to receive either PCO371 or placebo.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PCO371 | Small molecule | — | Oral |
Indications
No indication recorded.